UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trial of Psilocybin versus Escitalopram for Depression

The New England journal of medicine, 2021-04, Vol.384 (15), p.1402-1411

2021

Volltextzugriff (PDF)

The dopamine theory of addiction: 40 years of highs and lows

Nature reviews. Neuroscience, 2015-05, Vol.16 (5), p.305-312

2015

Volltextzugriff (PDF)

Increased global integration in the brain after psilocybin therapy for depression

Nature medicine, 2022-04, Vol.28 (4), p.844-851

2022

Volltextzugriff (PDF)

Self-blinding citizen science to explore psychedelic microdosing

eLife, 2021-03, Vol.10

2021

Volltextzugriff (PDF)

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

The Lancet. Psychiatry, 2016-07, Vol.3 (7), p.619-627

2016

Volltextzugriff (PDF)

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Proceedings of the National Academy of Sciences - PNAS, 2012-02, Vol.109 (6), p.2138-2143

2012

Volltextzugriff (PDF)

Psychedelics and sexual functioning: a mixed-methods study

Scientific reports, 2024-02, Vol.14 (1), p.2181-2181, Article 2181

2024

Volltextzugriff (PDF)

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy

Scientific reports, 2024-07, Vol.14 (1), p.16524-15, Article 16524

2024

Volltextzugriff (PDF)

Psychedelic Psychiatry’s Brave New World

Cell, 2020-04, Vol.181 (1), p.24-28

2020

Volltextzugriff (PDF)

The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study

Neuropharmacology, 2013-05, Vol.68, p.195-201

2013

Volltextzugriff (PDF)

Cognitive function is related to fronto-striatal serotonin transporter levels – a brain PET study in young healthy subjects

Psychopharmacology, 2011-02, Vol.213 (2-3), p.573-581

2011

Volltextzugriff (PDF)

Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients

Neuropsychopharmacology (New York, N.Y.), 2008-09, Vol.33 (10), p.2435-2441

2008

Volltextzugriff (PDF)

Neural correlates of the DMT experience assessed with multivariate EEG

Scientific reports, 2019-11, Vol.9 (1), p.16324-13, Article 16324

2019

Volltextzugriff (PDF)

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Neuropsychopharmacology (New York, N.Y.), 2019-06, Vol.44 (7), p.1328-1334

2019

Volltextzugriff (PDF)

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression

Psychological medicine, 2024-06, Vol.54 (8), p.1717-1724

2024

Volltextzugriff (PDF)

Human brain effects of DMT assessed via EEG-fMRI

Proceedings of the National Academy of Sciences - PNAS, 2023-03, Vol.120 (13), p.e2218949120-e2218949120

2023

Volltextzugriff (PDF)

Psychological and physiological effects of extended DMT

Journal of psychopharmacology (Oxford), 2024-01, Vol.38 (1), p.56-67

2024

Volltextzugriff (PDF)

Neuroimaging in psychedelic drug development: past, present, and future

Molecular psychiatry, 2023-09, Vol.28 (9), p.3573-3580

2023

Volltextzugriff (PDF)

Psychedelics and health behaviour change

Journal of Psychopharmacology, 2022-01, Vol.36 (1), p.12-19

2022

Volltextzugriff (PDF)

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression

Psychological medicine, 2024-01, Vol.54 (1), p.178-192

2024

Volltextzugriff (PDF)

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis

Psychiatry research, 2023-09, Vol.327, p.115349-115349, Article 115349

2023

Volltextzugriff (PDF)

Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans

Journal of psychopharmacology (Oxford), 2021-04, Vol.35 (4), p.459-468

2021

Volltextzugriff (PDF)

Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge

Biological psychiatry (1969), 2023-06, Vol.93 (12), p.1089-1098

2023

Volltextzugriff (PDF)

Reply to: No Clear Evidence of Reduced Brain Serotonin Release Capacity in Patients With Depression

Biological psychiatry (1969), 2023-06, Vol.93 (12), p.e63-e64

2023

Volltextzugriff (PDF)

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression

Journal of psychopharmacology (Oxford), 2024-05, Vol.38 (5), p.458-470

2024

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(72)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trial of Psilocybin versus Escitalopram for Depression

The dopamine theory of addiction: 40 years of highs and lows

Increased global integration in the brain after psilocybin therapy for depression

Self-blinding citizen science to explore psychedelic microdosing

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Psychedelics and sexual functioning: a mixed-methods study

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy

Psychedelic Psychiatry’s Brave New World

The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study

Cognitive function is related to fronto-striatal serotonin transporter levels – a brain PET study in young healthy subjects

Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients

Neural correlates of the DMT experience assessed with multivariate EEG

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression

Human brain effects of DMT assessed via EEG-fMRI

Psychological and physiological effects of extended DMT

Neuroimaging in psychedelic drug development: past, present, and future

Psychedelics and health behaviour change

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis

Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans

Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge

Reply to: No Clear Evidence of Reduced Brain Serotonin Release Capacity in Patients With Depression

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression

Aktive Filter

Suchergebnisse filtern